| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 28 Apr 2026 | 28 Apr 2026 |
| Please find the attached Board Meeting Outcome PLease find the attached outcome of the board meeting | ||
| Board Meeting | 23 Feb 2026 | 23 Feb 2026 |
| Please find the attached Outcome of Board Meeting. | ||
| Board Meeting | 4 Feb 2026 | 31 Jan 2026 |
| Cresanto Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2026 inter alia to consider and approve 1. Un-audited Financial Results of the Company for the third quarter ended 31st December 2025. 2. Limited Review Report for the third quarter ended 31st December 2025. 3. Any other business with the permission of chair. Please find the attached outcome of the Board Meeting Please find the attached Outcome of Board Meeting (As Per BSE Announcement Dated on:04.02.2026) | ||
| Board Meeting | 5 Nov 2025 | 29 Oct 2025 |
| Raymed Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2025 inter alia to consider and approve Please find the attached Intimation of Board Meeting Please find the attached outcome of Board meeting Please find the attached outcome of Board Meeting. (As Per BSE Announcement Dated on:05.11.2025) | ||
| Board Meeting | 12 Aug 2025 | 7 Aug 2025 |
| Raymed Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve Please find the attached Intimation. Please find the attached outcome of the Board meeting. (As Per BSE Announcement Dated on: 12/08/2025) | ||
| Board Meeting | 1 Aug 2025 | 29 Jul 2025 |
| Raymed Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 inter alia to consider and approve Plese find the attached Intimation of Board Meeting Please find the attached Outcome of Board Meeting (As Per BSE Announcement Dated on: 01.08.2025) | ||
| Board Meeting | 22 May 2025 | 15 May 2025 |
| Raymed Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 inter alia to consider and approve Financial results of the company for quarter and year ended 31st March 2025 Please find the attached outcome of Board Meeting. (As per BSE Announcement Dated on 22/05/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Reg. No. INM000010940, SEBI RA Regn. No: INH000000248, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
